Marie Bouillez

Director/Board Member at

PharmaFluidics NV

45 year

27 connections

Commercial Services

Technology Services

Health Technology

Profile

Marie Bouillez currently works at PharmaFluidics NV, as Director, Advanced Engineering Accelerator SA, as Director from 2021, E-Health Venture NV, as Director from 2020, and Theodorus Investment Funds, as Partner from 2017.
Ms. Bouillez also formerly worked at Orgenesis, Inc., as Director in 2016, Catalent Gosselies SA, as Director, Epics Therapeutics SA, as Managing Director, and Charleroi Brussel South Biopark Dev SA, as Managing Director.
Ms. Bouillez received her graduate degree from Solvay Business School of Economics & Management.

Marie Bouillez active positions

Companies	Position	Start
PharmaFluidics NV PharmaFluidics NV Electronic Equipment/InstrumentsElectronic Technology Develops micro chip liquid chromatography cartridges for analysis of complex biological samples	Director/Board Member	-
Theodorus Investment Funds Theodorus Investment Funds Investment ManagersFinance Theodorus invests in companies located in Belgium. The firm targets companies operating in the fields of biotech, medtech, digital and engineering applications. It provides financing for seed and early stage capital requirements with an investments size ranging from EUR 0.25 to 2.5 million. It also acts as a lead investor.	Private Equity Investor	2007-06-30
Advanced Engineering Accelerator SA Advanced Engineering Accelerator SA Miscellaneous Commercial ServicesCommercial Services Provides business support services for engineering firms	Director/Board Member	2021-03-31
E-Health Venture NV E-Health Venture NV Information Technology ServicesTechnology Services Provides digital healthcare services	Director/Board Member	2020-07-16

All active positions of Marie Bouillez

Former positions of Marie Bouillez

Companies	Position	End
ORGENESIS INC.	Director/Board Member	2016-12-04
Epics Therapeutics SA Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology	Chief Executive Officer	-
Charleroi Brussel South Biopark Dev SA Charleroi Brussel South Biopark Dev SA Miscellaneous Commercial ServicesCommercial Services Provides biotechnology development services	Chief Executive Officer	-
Catalent Gosselies NV Catalent Gosselies NV BiotechnologyHealth Technology Provides cell therapy manufacturing services	Director/Board Member	-

See the detail of Marie Bouillez's experience

Training of Marie Bouillez

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Marie Bouillez's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Orgenesis, Inc. Orgenesis, Inc. Packaged SoftwareTechnology Services Offers POCare services platform for biotech companies and hospitals to supply their products and develops potential of cell and gene therapies	Technology Services
Charleroi Brussel South Biopark Dev SA Charleroi Brussel South Biopark Dev SA Miscellaneous Commercial ServicesCommercial Services Provides biotechnology development services	Commercial Services
Catalent Gosselies NV Catalent Gosselies NV BiotechnologyHealth Technology Provides cell therapy manufacturing services	Health Technology
Solvay Business School of Economics & Management Solvay Business School of Economics & Management Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
PharmaFluidics NV PharmaFluidics NV Electronic Equipment/InstrumentsElectronic Technology Develops micro chip liquid chromatography cartridges for analysis of complex biological samples	Electronic Technology
Theodorus Investment Funds Theodorus Investment Funds Investment ManagersFinance Theodorus invests in companies located in Belgium. The firm targets companies operating in the fields of biotech, medtech, digital and engineering applications. It provides financing for seed and early stage capital requirements with an investments size ranging from EUR 0.25 to 2.5 million. It also acts as a lead investor.	Finance
Epics Therapeutics SA Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology	Commercial Services
Advanced Engineering Accelerator SA Advanced Engineering Accelerator SA Miscellaneous Commercial ServicesCommercial Services Provides business support services for engineering firms	Commercial Services
E-Health Venture NV E-Health Venture NV Information Technology ServicesTechnology Services Provides digital healthcare services	Technology Services